ENDRA Life Sciences Inc.

4.24
0.19 (4.69%)
At close: Mar 31, 2025, 10:31 AM

ENDRA Life Sciences Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -10.06M -13.18M -11.23M -11.73M -13.31M -9.8M -5.38M -2.78M -2.28M -2.18M
Depreciation & Amortization 275.45K 234.26K 224.41K 165.25K 115.01K 68.32K 61.48K 64.94K 72.22K 37.24K
Stock-Based Compensation 996.43K 1.2M 1.44M 2.1M 1.4K 1.37K 1K 230.33K 309.84K 259.49K
Other Working Capital -239.11K 222.8K -566.44K -1.07M 651.83K 5.97M -71.21K 196.08K 203.09K -91.99K
Other Non-Cash Items 162.91K 1.39K -298.73K 2.33M 4M 2.38M 1.72M 909.5K 686.34K 639.12K
Deferred Income Tax n/a n/a n/a -2.1M -1.4K n/a n/a n/a 25K n/a
Change in Working Capital -923.32K -1.03M -1.26M -1.55M 597.83K -359.08K 298.66K 254.98K 343.07K -152.2K
Operating Cash Flow -9.55M -12.77M -11.12M -10.77M -8.59M -7.7M -3.3M -1.32M -842.73K -1.4M
Capital Expenditures -33.88K -202.58K -45K -51.33K -43.59K -100K -7.86K n/a -133.81K -275.37K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 9.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -24.72K -202.58K -45K -51.33K -43.59K -100K -7.86K n/a -133.81K -275.37K
Debt Repayment n/a n/a n/a 337.08K 2.49M 935.3K 175K 1.44M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid -840 -7.79K -121.07K -395.55K -4.22M n/a n/a n/a n/a n/a
Other Financial Acitivies 1.04M n/a 2.91M 5.15M 15.78M 7.74M 8.59M 5K n/a n/a
Financial Cash Flow 7.52M 8.4M 13.4M 11.88M 8.34M 8.67M 8.77M 1.44M 839.22K 1.75M
Net Cash Flow -2.06M -4.57M 2.23M 1.05M -297.17K 869.5K 5.46M 125.83K -137.31K 78.42K
Free Cash Flow -9.58M -12.97M -11.17M -10.82M -8.63M -7.8M -3.31M -1.32M -976.54K -1.67M